𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A disposition kinetic study of tramadol in rat perfused liver

✍ Scribed by Mohammad-Reza Rouini; Mahmoud Ghazi-Khansari; Yalda H. Ardakani; Zahra Dasian; Hoda Lavasani

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
102 KB
Volume
29
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A recirculated perfusion system was used to investigate the metabolism of tramadol, an analgesic agent, in the isolated perfused rat liver. Tramadol was added to the perfusion medium at a concentration of 300 ng/ml, and the perfusate samples were collected for 180 min. The concentration of tramadol and its three main metabolites O‐desmethyltramadol (M1) and N‐desmethyltramadol (M2) and N,O‐didesmethyltramadol (M5) were determined in perfusate samples by a rapid HPLC method. All through the study, the phase I metabolism of tramadol led to the formation of M1 metabolite from early sampling points while M5 metabolite was detectable after 50 min in 6 out of 10 perfused livers and the M2 metabolite was not detectable in any experiment. The kinetic parameters of tramadol and two detectable metabolites (M1 and M5) were then calculated in perfusate samples. The tramadol concentration decreased from 297.8 to 159.6 ng/ml, with a mean half‐life of 232.4 min and a hepatic clearance of 0.73 ml/min. After 180 min, the mean concentration of M1 reached 59.5 ng/ml, resulting in a metabolic ratio of 16%, while the formation of M5 metabolite continued to a mean concentration of 14.6 ng/ml resulting in a metabolic ratio of 2% using AUC~(0−180min)~. Copyright © 2008 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Disposition kinetics of 7,12-dimethylben
Disposition kinetics of 7,12-dimethylbenz(a)anthracene in rats
✍ Dr Sarfaraz K. Niazi; Musarrat Hussain 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

## Abstract One of the most potent carcinogens is 7,12‐dimethylbenz(a)anthracene (7,12‐DMBA), which is used routinely to conduct studies to evaluate carcinogen inhibitors. Its pharmacokinetics have not been reported in the literature. In view of its significant effects on drug metabolizing enzymes

Further observations on the uptake and e
Further observations on the uptake and effects of phosphonates in perfused rat liver studied by 31P-NMR
✍ Koenraad Bruynseels; Paul Van Hecke; Florent Vanstapel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

We examined the route of uptake of 2-aminoethylphosphonate (NEthPo) and of phenylphosphonate (PhePo; 10 mM each) in perfused liver by 31 P-NMR. Uptake of NEthPo was concentrative. The rate of uptake was reduced to 21 AE 2% (n = 3; all percentages refer to control rates) by substituting choline for N

Effects of intravenous lipid as a source
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion
✍ Nuzhat Zaman; Yun K. Tam; Lawrence D. Jewell; Ronald T. Coutts 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views

The eects on liver function and hepatic lidocaine elimination using 20% Intralipid 1 as a source of non-protein calories (30%) in parenteral nutrition were studied using an isolated rat liver perfusion procedure. Rats were randomly assigned to one of the three treatment groups: PNL group (n = 6), co

On the inhibition of hepatic glycogenoly
On the inhibition of hepatic glycogenolysis by fructose. A 31P-NMR study in perfused rat liver using the fructose analogue 2,5-anhydro-D-mannitol
✍ K. Bruynseels; N. Bergans; N. Gillis; F. van Dorpen; P. Van Hecke; W. Stalmans; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Inhibition of hormone-stimulated hepatic glycogenolysis by fructose (Fru) has been attributed to accumulation of the competitive inhibitor Fru1P and/or to the associated depletion of the substrate phosphate (P i ). To evaluate the relative importance of either factor, we used the Fru analogue 2,5-an

Influence of chronic hepatic failure on
Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride
✍ Phisit Khemawoot; Chiharu Maruyama; Hirotaka Tsukada; Hiroyo Noda; Junko Ishizak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract The influence of chronic hepatic failure on the disposition kinetics of valproate (VPA) excretion via a phase II reaction was examined in rats treated with carbon tetrachloride (1.0 mg/kg, s.c., 3 times a week) for 2 or 3 months. There was no significant difference in the plasma concent